EUVIMEDEUVIMED entdecken
Crossref

De Novo Design of Efficient NIR‐II‐Activated Heavy‐Atom‐Free Type‐I Photosensitizer for Anti‐Tumor Photoimmunotherapy

Huan Chen iD, Yu Wang, Zhangxin He, Yingpeng Wan, Chen Cao iD, Ziwei Lu, Yijian Gao, Xiao Cui, Ka-Wai Lee iD, Ji-Hua Tan iD, Wenchang Xu, Yuliang Yang und 5 weitere

Advanced Materials · 2025-08 · 37 (33)

DOI: 10.1002/adma.202501919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 04.06.2025. Verfasst von Huan Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center of Super-Diamond and Advanced Films (COSDAF), Department of Chemistry, City University of Hong Kong, Hong Kong, 000000, P. R. China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Infrared Rays, Immunotherapy, Antineoplastic Agents. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Specially Appointed Professorship, Leading Talents of Innovation and Entrepreneurship of Gusu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type‐I photosensitizers (PSs) are considered to be efficient agents for overcoming the oxygen‐dependent deficiency of traditional photodynamic therapy (PDT). However, it is still challenging to design type‐I PSs that can be activated by the second near‐infrared (NIR‐II) irradiation. Herein, a series of organic heavy‐atom‐free molecules are designed (named as CTU1 , CTU2 , and CTU3 ) and exhibit strong absorption bands over the first near‐infrared and NIR‐II regions. Among them, water‐dispersible CTU3 nanoparticles (NPs) show strong J ‐aggregate characteristics and a good NIR‐II absorption band, resulting in highly efficient •O 2 − generation upon irradiation of 1064 nm light. In addition, the CTU3 NPs also exhibit a high photothermal conversion efficiency of 88.6%. In vitro and in vivo experiments show that CTU3 NPs have superior PDT and photothermal therapy (PTT) effects, which can further induce immunogenic cell death and activate immune cells in 4T1 tumor‐bearing mice for combined PDT/PTT anti‐tumor photoimmunotherapy against refractory tumors. This work presents a paradigm of de novo design of NIR‐II light‐activated type‐I PS for combinational photoimmunotherapy of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsInfrared RaysImmunotherapyAntineoplastic AgentsAnimalsMiceCell Line, TumorPhotochemotherapyNanoparticlesFemaleHumansMice, Inbred BALB CNeoplasms

Stichwörter der Autor:innen

Heavy‐atom‐freeNIR‐II‐activatedPhotoimmnuotherapyPhotosensitizerType‐I PDT

Substanzen

Photosensitizing AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Center of Super-Diamond and Advanced Films (COSDAF), Department of Chemistry, City University of Hong Kong, Hong Kong, 000000, P. R. China.
  • College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, P. R. China.
  • The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou, 215000, P. R. China.
  • Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, P. R. China.
  • Shenzhen BGI Huo-Yan Engineering Technology Co., Ltd, Shenzhen, 518083, P. R. China.

ORCID-Profile: Huan Chen, Chen Cao, Ka-Wai Lee, Ji-Hua Tan, Yali Wang, Shengliang Li, Chun-Sing Lee

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Specially Appointed Professorship, Leading Talents of Innovation and Entrepreneurship of Gusu
  • Suzhou International Joint Laboratory for Diagnosis and Treatment of Brain Diseases
  • Suzhou Science and Technology Program
  • University Grants Committee

Zitieren

APA

Chen, H., Wang, Y., He, Z., Wan, Y., Cao, C., Lu, Z., Gao, Y., Cui, X., Lee, K. W., Tan, J. H., Xu, W., Yang, Y., Li, X., Wang, Y., Hou, J., Li, S., & Lee, C. S. (2025). De Novo Design of Efficient NIR‐II‐Activated Heavy‐Atom‐Free Type‐I Photosensitizer for Anti‐Tumor Photoimmunotherapy. Advanced Materials, 37(33). https://doi.org/10.1002/adma.202501919

Vancouver

Chen H, Wang Y, He Z, Wan Y, Cao C, Lu Z, et al. De Novo Design of Efficient NIR‐II‐Activated Heavy‐Atom‐Free Type‐I Photosensitizer for Anti‐Tumor Photoimmunotherapy. Advanced Materials. 2025;37(33). doi:10.1002/adma.202501919

BibTeX
@article{Chen2025,
  author = {Chen, Huan and Wang, Yu and He, Zhangxin and Wan, Yingpeng and Cao, Chen and Lu, Ziwei and Gao, Yijian and Cui, Xiao and Lee, Ka-Wai and Tan, Ji-Hua and Xu, Wenchang and Yang, Yuliang and Li, Xiliang and Wang, Yali and Hou, Jianquan and Li, Shengliang and Lee, Chun-Sing},
  title = {De Novo Design of Efficient NIR‐II‐Activated Heavy‐Atom‐Free Type‐I Photosensitizer for Anti‐Tumor Photoimmunotherapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {33},
  doi = {10.1002/adma.202501919}
}
Kostenlos starten →